PUBLISHER: The Business Research Company | PRODUCT CODE: 2127572
PUBLISHER: The Business Research Company | PRODUCT CODE: 2127572
Retrievable vena cava filters are small, cage-like medical devices implanted in the inferior vena cava, the largest vein in the human body, to prevent blood clots from traveling from the lower extremities to the lungs and causing pulmonary embolism. These filters are intended for temporary placement in patients at risk of venous thromboembolism (VTE) and can be removed once the risk decreases, providing flexibility and minimizing long-term complications associated with permanent filters.
The primary product types of retrievable vena cava filters include retrievable inferior vena cava filters, convertible vena cava filters, optional vena cava filters, and tethered retrievable filters. Retrievable inferior vena cava filters refer to implantable medical devices designed to capture blood clots within the vena cava and prevent their movement to the lungs while enabling removal when they are no longer required. These products support procedures such as filter placement procedures and filter retrieval procedures and are distributed through direct sales, medical device distributors, and online procurement channels. They are used in applications including deep vein thrombosis, pulmonary embolism prevention, venous thromboembolism management, trauma patients, and bariatric surgery patients, serving end users such as hospitals, specialty clinics, ambulatory surgical centers, interventional radiology centers, and cardiac and vascular care centers.
Tariffs are influencing the retrievable vena cava filters market by increasing the cost of imported medical-grade metals, nitinol components, catheter delivery systems, precision manufacturing equipment, and vascular intervention accessories used in filter production. The resulting increase in manufacturing and procurement costs is affecting retrievable inferior vena cava filters, convertible vena cava filters, optional vena cava filters, and tethered retrievable filters, particularly across North America, Europe, and Asia-Pacific regions that rely on global medical device supply chains. Higher device costs may place financial pressure on hospitals, specialty clinics, and interventional radiology centers while influencing purchasing decisions. However, tariffs are also encouraging domestic medical device manufacturing, regional supplier diversification, and investment in localized production capabilities, improving long-term supply chain resilience and market stability.
The retrievable vena cava filter market research report is one of a series of new reports from The Business Research Company that provides retrievable vena cava filter market statistics, including retrievable vena cava filter industry global market size, regional shares, competitors with a retrievable vena cava filter market share, detailed retrievable vena cava filter market segments, market trends and opportunities, and any further data you may need to thrive in the retrievable vena cava filter industry. This retrievable vena cava filter market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The retrievable vena cava filter market size has grown strongly in recent years. It will grow from $1.07 billion in 2025 to $1.17 billion in 2026 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to increasing incidence of deep vein thrombosis, rising prevalence of pulmonary embolism cases, growing number of trauma and critical care patients, expanding use of interventional radiology procedures, increasing awareness regarding venous thromboembolism prevention.
The retrievable vena cava filter market size is expected to see strong growth in the next few years. It will grow to $1.68 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to growing demand for minimally invasive vascular interventions, increasing adoption of retrievable and bioconvertible filter technologies, rising aging population at risk of thromboembolic disorders, expanding access to specialized vascular care services, growing investments in advanced cardiovascular medical devices. Major trends in the forecast period include increasing adoption of retrievable filters over permanent filter alternatives, growing preference for low profile filter designs to support minimally invasive procedures, rising development of advanced retrieval mechanisms to improve filter removal success rates, expanding utilization of convertible and optional vena cava filters in high risk patients, growing focus on reducing long term complications associated with filter implantation.
The increasing prevalence of cardiovascular diseases is expected to drive the growth of the retrievable vena cava filter market in the coming years. Cardiovascular diseases are a group of conditions that affect the heart and blood vessels, including coronary artery disease, stroke, deep vein thrombosis, and pulmonary embolism, which may result in serious complications and mortality if not properly managed. The prevalence of cardiovascular diseases is increasing due to the growing adoption of sedentary lifestyles, as limited physical activity contributes to obesity, hypertension, elevated cholesterol levels, and impaired blood circulation, which are major risk factors for heart disease and stroke. Retrievable vena cava filters are used in cardiovascular conditions to temporarily prevent blood clots from moving through the veins to the lungs, thereby lowering the risk of pulmonary embolism in patients with venous thromboembolism or those who cannot undergo anticoagulant therapy. For instance, in September 2025, according to the Heart Failure Epidemiology and Outcomes Statistics, a US-based cardiovascular research organization, the number of Americans living with heart failure was estimated at 6.7 million in 2024 and is expected to reach 8.7 million by 2030. Therefore, the increasing prevalence of cardiovascular diseases is contributing to the growth of the retrievable vena cava filter market.
The increasing healthcare expenditure is expected to drive the growth of the retrievable vena cava filter market in the coming years. Healthcare expenditure refers to the overall spending on healthcare products and services, including hospital care, physician services, medical devices, and preventive healthcare initiatives. Healthcare expenditure is increasing due to the rising burden of chronic diseases, as long-term disease management, regular monitoring, advanced medical procedures, and extended medication requirements significantly raise healthcare costs. Retrievable vena cava filters benefit from increased healthcare spending by allowing hospitals and healthcare providers to implement advanced clot-prevention devices for the management of deep vein thrombosis and pulmonary embolism among high-risk patients. For instance, in January 2026, according to the Centers for Medicare and Medicaid Services (CMS), a US-based federal agency, physician and clinical services expenditures increased by 8.1% to $1,109.7 billion in 2024, representing faster spending growth compared to the 7.4% rise recorded in 2023. Therefore, the increasing healthcare expenditure is supporting the growth of the retrievable vena cava filter market.
The increasing number of trauma and accident cases is expected to drive the growth of the retrievable vena cava filter market in the coming years. Trauma and accident cases refer to injuries caused by road traffic accidents, falls, workplace incidents, violence, or other physical events that result in severe bodily damage and require immediate medical attention. The number of trauma and accident cases is increasing mainly due to the rising volume of road traffic worldwide, fueled by rapid urbanization and increased vehicle ownership, which raises the risk of collisions and severe injuries. Retrievable vena cava filters are used in trauma and accident cases to temporarily prevent blood clots from traveling from deep veins to the lungs, thereby reducing the risk of pulmonary embolism in patients who are immobilized, critically injured, or unable to receive anticoagulant treatment. For instance, in January 2026, according to the International Transport Forum, a France-based intergovernmental organization, France recorded 3,193 road fatalities in 2024, representing an increase of 26 deaths compared to 2023. Therefore, the increasing number of trauma and accident cases is contributing to the growth of the retrievable vena cava filter market.
Major companies operating in the retrievable vena cava filter market report are Cardinal Health Inc., Johnson & Johnson Services Inc., Becton Dickinson and Company, Boston Scientific Corporation, B. Braun SE, Cook Medical LLC, Cordis Corporation, Argon Medical Devices Inc., Lifetech Scientific Corporation, Bio2 Medical Inc., ALN Implants Chirurgicaux, Rex Medical L.P.
North America was the dominating region in the retrievable vena cava filter market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the retrievable vena cava filter market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the retrievable vena cava filter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The retrievable vena cava filter market consists of sales of delivery systems, retrieval kits, and associated procedural services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including hospitals, specialty clinics, ambulatory surgical centers, distributors, and healthcare providers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Retrievable Vena Cava Filter Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses retrievable vena cava filter market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for retrievable vena cava filter ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The retrievable vena cava filter market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.